Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POLCAGB: Neoadjuvant Chemotherapy vs Chemoradiotherapy in Gallbladder Cancer
NCT02867865Phase 3Active, not recruiting
- Sponsor
- Tata Memorial Hospital
- Start
- Sep 2016
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine, cisplatin in gallbladder cancer, sponsored by Tata Memorial Hospital. Started Sep 2016; status: active, not recruiting.
02
Drugs
gemcitabinecisplatin
03
Conditions
gallbladder cancer
Beyond the preview
Go deeper on NCT02867865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02867865.